The investment from South Korean parent company SK Inc. is projected to create 100 long-term, high-skilled jobs while strengthening domestic capabilities in active pharmaceutical ingredients, peptides and advanced therapy supply.
The investment from South Korean parent company SK Inc. is projected to create 100 long-term, high-skilled jobs while strengthening domestic capabilities in active pharmaceutical ingredients, peptides and advanced therapy supply.